UroGen Approaches A Big Expansion In Bladder Cancer

 
• By Jessica Merrill

The oncology company is preparing for the launch of UGN-102 for bladder cancer. CEO Liz Barrett talked to Scrip about the company’s next growth phase.

edge
UroGen is on the edge of a new growth phase • Source: Shutterstock

More from Anticancer

More from Therapy Areas